Delivery Order SPE2DB20D2104-SPE2DB26FMAYM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging (30-count) with a ceiling value of $2,705.69. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging of 30 units, with a ceiling value of $1,927.41. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,494.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adzenys XR-ODT 15.7 mg tablets (30-count unit dose packaging). The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adzenys XR-ODT 3.1 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,063.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement awarded through competitive bidding. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,504.87 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adzenys XR-ODT 9.4 mg tablets in unit-dose packaging (30 tablets). This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.67 to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 12.5 mg tablets (30-count unit dose packages) with a completion date of September 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Adzenys XR-ODT 18.8 mg tablet units. The contract has a firm-fixed price of $1,580.82 and a completion date of September 27, 2024. It is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAYMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $2,246.98 and represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen continues to support the Defense Logistics Agency's medical supply chain requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's role as a prime pharmaceutical vendor demonstrates its ongoing capacity to fulfill federal medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/27/25 |